These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 34870709)

  • 1. Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma.
    Guan J; Weng J; Ren Q; Zhang C; Hu L; Deng W; Lu S; Dong X; Li W; Li Y; Wang W
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34870709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL3 overexpression affects the malignant behavior of oral squamous cell carcinoma cells via the MAPK signaling pathway.
    Weng J; Ren Q; Li Z; Wang W; Guan J
    J Oral Pathol Med; 2021 Oct; 50(9):902-910. PubMed ID: 34392586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
    Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
    Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
    BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
    Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S
    Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway.
    Qi YL; Li Y; Man XX; Sui HY; Zhao XL; Zhang PX; Qu XS; Zhang H; Wang BX; Li J; Qi SF; Jia LL; Luan HY; Zhang CB; Wang WQ
    J Cell Physiol; 2020 May; 235(5):4756-4765. PubMed ID: 31667838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX2 enhances natural killer cell-mediated immunotherapy against head and neck squamous cell carcinoma through up-regulating CXCL14.
    Wang H; Nan S; Wang Y; Xu C
    J Cell Mol Med; 2021 May; 25(10):4596-4607. PubMed ID: 33733587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETV5 facilitates tumor progression in head-neck squamous cell carcinoma.
    Yu S; Ma Z; Chen T; Wang H; Yao Q; Li J; Cheng J
    Oral Dis; 2024 May; 30(4):2004-2017. PubMed ID: 37649213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
    Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
    BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway.
    Wu YL; Liu W; Zhao T; Jin J
    Med Oncol; 2024 May; 41(6):163. PubMed ID: 38777998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma.
    Feng X; Zheng Z; Wang Y; Song G; Wang L; Zhang Z; Zhao J; Wang Q; Lun L
    Exp Biol Med (Maywood); 2021 Mar; 246(5):538-546. PubMed ID: 33241710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
    Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
    Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACSL4 upregulates IFI44 and IFI44L expression and promotes the proliferation and invasiveness of head and neck squamous cell carcinoma cells.
    Rupa D; Chuang HW; Hu CE; Su WM; Wu SR; Lee HS; Yuan TC
    Cancer Sci; 2024 Sep; 115(9):3026-3040. PubMed ID: 38989827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C
    Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
    Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
    Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L
    Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SFRP1 mediates cancer-associated fibroblasts to suppress cancer cell proliferation and migration in head and neck squamous cell carcinoma.
    Dong L; Li Y; Song X; Sun C; Song X
    BMC Cancer; 2024 Sep; 24(1):1165. PubMed ID: 39300373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
    Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
    Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
    Yu B; Zhang Y; Wu K; Wang L; Jiang Y; Chen W; Yan M
    J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.